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Author Summary 
 
Fibronectin is a protein that exists in vertebrates in two distinct forms, one present in the blood and the 
other in blood vessel walls. In mammals, fibronectin is important for the development of blood vessels 
before birth, but the vascular function is not known from birth to adulthood. We present important results 
from three genetically modified mouse models, showing that at least one of the two fibronectin forms is 
required for the proper function and integrity of blood vessels during this period. We show that 
fibronectin can transfer from the blood into the vessel wall and can rescue the integrity of blood vessels 
in the absence of the vessel form. This represents an important biological mechanism to maintain the 
health of blood vessels. Our data also highlight the importance of both fibronectin forms in producing and 
organizing the cell microenvironment, with a higher contribution from the fibronectin form residing in the 
blood vessel walls. Together, our findings show that fibronectin from the blood acts as a safeguard to 
maintain the health of blood vessels, and both fibronectin forms play crucial roles in development and 
support of the blood vessel microenvironment. 
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Abstract 
 
Fibronectin (FN) exists in two forms - plasma FN (pFN) and cellular FN (cFN). Although the role of FN in 
embryonic blood vessel development is well established, its function and the contribution of individual 
isoforms in early postnatal vascular development are poorly understood. Here we employed a tamoxifen-
inducible cFN knockout (cFN iKO) mouse model to study the consequences of postnatal cFN deletion in 
smooth muscle cells (SMC), the major cell type in the vascular wall. Deletion of cFN influences collagen 
deposition, but does not affect life span. Unexpectedly, pFN translocated to the aortic wall in the cFN iKO 
and in control mice, possibly rescuing the loss of cFN. Postnatal pFN deletion did not show a histological 
aortic phenotype. Double knockout (dKO) mice lacking both, cFN in SMCs and pFN, resulted in postnatal 
lethality. These data demonstrate a safeguard role of pFN in vascular stability and the dispensability of 
the individual FN isoforms in postnatal vascular development. Complete absence of FNs in the dKOs 
resulted in a disorganized tunica media of the aortic wall. Matrix analysis revealed common and 
differential roles of the FN isoforms in guiding the assembly/deposition of elastogenic extracellular matrix 
proteins in the aortic wall. In addition, we determined with two cell culture models that that the two FN 
isoforms acted similarly in supporting matrix formation with a greater contribution from cFN. Together, 
these data show that pFN exerts a critical role in safeguarding vascular organization and health, and that 
the two FN isoforms function in an overlapping as well as distinct manner to maintain postnatal vascular 
matrix integrity. 
 
Abbreviations: cFN-cellular fibronectin; cFN iKO-cellular fibronectin inducible knockout; dKO-double 
knockout; ECM-extracellular matrix; EDA-extra domain-A; EDB-extra domain-B; FN-Fibronectin; KO-
knockout; pFN-plasma fibronectin; SMA-smooth muscle α-actin; SMC-smooth muscle cell.
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Introduction 1 
 2 
Fibronectin (FN) is an abundant and ubiquitously expressed protein in the extracellular matrix (ECM) of 3 
various connective tissues as well as in blood of vertebrates [1,2]. Even though coded by a single gene [3], 4 
it exists in multiple isoforms as a result of alternate splicing [4]. Each monomer of FN consists of three 5 
types of repeating units, FNI, FNII and FNIII domains (Fig 1A) [5]. Alternative splicing occurs within the 6 
central array of FNIII repeats, leading to either inclusion or exclusion of the FNIII EDA and EDB domains 7 
(Fig 1A). Another region of alternative splicing occurs towards the C-terminus of this array, the V region 8 
[6]. FNs occur in two principal forms, the soluble plasma FN (pFN) circulating in the blood, and the cellular 9 
FN (cFN), which polymerizes into insoluble fibers in the ECM of tissues including blood vessels [7]. pFN is 10 
synthesized exclusively in the liver by hepatocytes [8,9], and shows a relatively simple splicing pattern 11 
lacking the EDA and EDB domains, although forms with and without the V region exist [10]. The soluble 12 
pFN circulates in blood at a high concentration of ~0.6 mg/ml in mice and ~0.3 mg/ml in humans [11,12]. 13 
The cFN consists of a much larger and more heterogeneous group of isoforms, with either EDA or EDB or 14 
both domains present [4,13]. 15 
 16 
FN is broadly expressed in embryos and in adult tissue. It generally regulates a wide spectrum of cellular 17 
and matrix related functions which play crucial roles during development, including cell adhesion, 18 
migration, growth, differentiation and tissue repair [5,14]. The pivotal role of FN as a master organizer of 19 
ECM assembly is well documented by cell culture studies. The list of ECM proteins that depend on FN for 20 
incorporation into the ECM is growing and includes collagen I and III [15-19], fibrillin-1 (FBN-1) [20,21], 21 
fibulin (FBLN)-1 [22,23], Latent TGF-β Binding Protein (LTBP)-1 [24], LTBP-4 [25,26], fibrinogen [27], 22 
thrombospondin-1 [16], and tenascin-C [28]. FN is not only required for the initiation of these ECM 23 
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assemblies, but also for the stabilization of some of them [16,24,29]. However, whether this holds true in 24 
vivo is not established.  25 
  26 
The functional relevance of FN in critical physiological and pathological developmental processes is 27 
validated by severe defects in mice globally lacking the FN gene (Fn) [30], including vascular, mesodermal, 28 
and neural tube defects leading to death around embryonic day 9.5. Deletion of both EDA and EDB exons 29 
(present only in cFN) from Fn in mice also results in embryonic lethality with incomplete penetrance, 30 
displaying multiple embryonic cardiovascular defects [31]. Although pFN knockout mice have a normal 31 
life expectancy [32], it is a critical player in various pathologies. pFN supports neuronal survival and 32 
reduces infarct size following cerebral ischemia [32]. It is also important in thrombosis regulating 33 
thrombus stability and growth [33,34]. pFN worsens the course of atherosclerosis but promotes the 34 
formation of protective fibrous cap which prevents plaque rupture [35]. In humans, dysregulation of FN 35 
levels have been identified in various pathologies with cardiovascular manifestations, including 36 
atherosclerosis [36], myocardial infarction [37], Sturge-Weber Syndrome [38], and Ehlers-Danlos 37 
syndrome Type X [39]. Altered circulating pFN levels have been reported in patients with coronary heart 38 
disease [40,41], and ischemic heart disease [42]. These studies highlight the importance of FN during 39 
embryonic vascular development and in postnatal diseases associated with the cardiovascular system. 40 
The aim of this study was to elucidate the role of FN isoforms during postnatal vascular development with 41 
a focus on the elastic fiber-rich tunica media. To specifically delete cFN in smooth muscle cells (SMCs), the 42 
most prevalent cells in the tunica media, we employed tamoxifen-dependent Cre recombinase under a 43 
smooth muscle specific promoter. To discern the role of pFN in vascular development, a liver specific Cre 44 
mouse was used. Our study demonstrates the importance and function of FN isoforms during the 45 
development of the aorta in the early postnatal period.  46 
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Results 47 
 48 
It is well documented that FN is crucial in the development of blood vessels during embryogenesis 49 
[30,43,44]. The vascular wall further undergoes extensive development during the early postnatal period, 50 
including an expansion in total wall volume and wall thickness accompanied with a doubling of SMC 51 
number and an increase in matrix volume [45]. The role of FNs during this phase is not known, and thus 52 
we addressed it in this study with a focus on cellular and matrix integrity of the aortic vascular media.  53 
  54 
 55 
Efficacy and specificity of the inducible cellular fibronectin deletion in the aortic media 56 
 57 
We have generated a conditional knockout mouse model (cFN iKO) that allows postnatal, tamoxifen-58 
inducible deletion of cFN in SMC, the major cell type in the aortic media. Mice containing Fn flanked by 59 
loxP sites (Fn(fl/fl)) were crossed with an established transgenic mouse line (Sma-Cre-ERT2/+), in which the 60 
expression of the tamoxifen-dependent Cre-ERT2 recombinase is under the control of the mouse α-SMA 61 
promoter. After several breeding rounds, the cFN iKO genotype (Fn(fl/fl); Sma-Cre-ERT2/+) was produced 62 
(Fig 1B; top panel) [32,46]. The deletion of Fn, induced by intragastric tamoxifen injection (every day from 63 
P1-P3), was confirmed at P8 by a Fn specific RT-PCR of RNA isolated from the aortic media of the cFN iKO 64 
compared to control mice (Fig 1B; bottom panel). To further validate the efficiency and specificity of Cre 65 
recombinase expression in the Sma-Cre-ERT2/+ mice following early postnatal tamoxifen injection (P1-P3), 66 
a Reporter-Cre mouse strain (R26(fl/fl); Sma-Cre-ERT2/+) was generated. (Fig 1C; top panel). In this mouse, 67 
the lacZ reporter gene coding for β-galactosidase, is only transcribed in cells and tissues where Cre 68 
recombinase is expressed. Intense β-galactosidase staining of the aortic media harvested from tamoxifen-69 
induced Reporter-Cre mice, but not of the tamoxifen-induced Cre negative Reporter-Control (R26(fl/fl)) 70 
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mice confirmed an efficient and specific expression of the Cre recombinase in the tunica media, identified 71 
by α-SMA staining (Fig 1C; middle and bottom panel).  72 
 
Fig 1: Fibronectin and its deletion in the aortic media.  
A) Schematic diagram of FN isoforms, generated from the single Fn gene. pFN is synthesized and secreted 
by hepatocytes in the liver, and cFN is synthesized by vascular SMCs, among other mesenchymal cells. 
Alternatively spliced forms in mouse are indicated. B) Genotype of the inducible, smooth muscle specific 
cFN iKO mouse model (top panel). RT-PCR of Fn from total RNA isolated from the aortic media layer, 
confirming deletion of Fn in the cFN iKO post tamoxifen injection (bottom panel). Gapdh was used as a 
control. (n = 3) C) Genotype of the LacZ Reporter-Cre mouse strain (top panel). β-galactosidase (β-gal) 
staining of aortae from tamoxifen injected Reporter-control (R26(fl/fl)) and Reporter-Cre (R26(fl/fl); Sma-
Cre-ERT2/+) mice (middle panel) (n=3). Note positive blue staining in the Reporter-Cre (white arrowheads) 
and the absence of staining in the Reporter-control (black arrowheads) aortae. Immunostaining for α-SMA 
in control and in cFN iKO mice (bottom panel). Note that the expression of α-SMA in the tunica media is at 
the same topological location than the β-galactosidase staining in the Reporter-Cre, confirming that the 
induced Cre recombinase is specifically active in aortic SMCs (n=5). Scale bar represents 50 µm and asterisk 
(*) denotes aortic lumen in (C). 
 
 
Postnatal deletion of cellular fibronectin in aortic media leads to a mild phenotype 73 
 74 
Unexpectedly, tamoxifen-injected cFN iKO mice demonstrated a normal life span in the absence of any 75 
gross phenotype. To evaluate aortic tissue integrity of these mice, we performed histological analyses of 76 
the aortic wall (Fig 2A-2H). FN guides assembly of several ECM proteins in cell culture models, but whether 77 
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FN plays a similar role in vivo and what are the contributions of the individual FN isoforms has not been 78 
determined. Therefore, one major focus of this study was to analyze the contributions of FN to ECM 79 
assembly in the postnatal mouse aorta. FN acts as a scaffold for the assembly of collagen in cell culture 80 
[15-19]. However, deleting Fn in the tunica media of the cFN iKO mice led to an unexpected increase of 81 
collagen deposition at 3 months of age as compared to the control (Fig 2A-2C). Collagen deposition 82 
reverted back to control levels at 8 months of age (Fig 2E-2G). Despite the fact that cFN was deleted only 83 
in the tunica media, we observed differences in the adventitial collagen organization based on Masson’s 84 
Trichrome staining and quantification of picrosirius red staining. Up to 3 months of age the tamoxifen-85 
treated cFN iKO showed a loose collagen deposition in the adventitia (Fig 2B; triangles and 2D), whereas 86 
at 8 months the pattern reverted to a denser collagen matrix as compared to the control (Fig 2F; triangles 87 
and 2H). FN also promotes the assembly of fibrillin-1 containing microfibrils in cell culture [20,21]. 88 
Immunostaining of aortic sections for fibrillin-1 showed no changes in the aorta of cFN iKO as compared 89 
to the control (S1A and S1B Fig). Next, we investigated if postnatal deletion of cFN affects the formation 90 
of elastic lamellae in the aortic wall. The elastic lamellae were relatively normal, although they appeared 91 
to have more disruptions than the control mice (S1C and S1D Fig). However, quantification of breaks and 92 
forks normalized to the area did not show statistically significant differences (S1E and S1F Fig). Overall, 93 
postnatal deletion of cFN in medial SMCs led only to minor changes in the matrix organization that did 94 
not affect the overall health of the mice.  95 
 
Fig 2: Histological phenotypes in the smooth muscle specific inducible cFN iKO mice.   
Control mice and cFN iKO mice were treated with tamoxifen from P1-P3. A and B) Masson’s trichrome 
stained cross-sections of descending aorta at 3 months of age demonstrate higher amounts of collagen 
deposition in the media and loose collagen deposition in adventitia of cFN iKO mice (turquoise stain) (B) 
as compared to controls (A) (n=3). C and D) Quantification of collagen in the tunica media (C) and the 
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tunica adventitia (D) of picrosirius red stained aorta sections from 3 months old cFN iKO and control mice 
(n=4-8). Underlying data are provided in S1 Data. E and F) Masson's trichrome stained cross-sections of 
descending aorta demonstrate dense collagen deposition in the adventitia of cFN iKO mice at 8 months (F; 
triangles) as compared to controls (E; triangles) (n=3). M and A indicates tunica media and tunica 
adventitia respectively and the scale bar represents 50µm in A-B and E-F. G-H) Quantification of collagen 
in the tunica media (G) and tunica adventitia (H) of picrosirius red stained sections of aorta of 8 months 
old cFN iKO and control mice (n=4-8). Parameters quantified are total collagen intensity (Total), mean 
collagen pixel intensity (Mean), and area of collagen distribution in µm2 (Area) in the tunica 
media/adventitia. Note that the changes in collagen deposition observed at 3 months (A-D) revert back at 
8 months (E-H). Underlying data are provided in S1 Data.  I and J) Immunofluorescence staining of the 
aortic wall with anti-EDA FN antibody (specific for cFN) shows an effective deletion and reduction of cFN 
in cFN iKO mice (I) as compared to control mice (J) (arrowheads) (n=3). K) Quantification of 
immunofluorescence staining shown in (I) and (J). L and M) Immunofluorescence staining of aortae from 
control and cFN iKO mice with an antibody against total FN (pFN and cFN). Note there is no reduction of 
total FN staining in the media of cFN iKO mice (L) as compared to the control mice (M) (n=4). N) 
Quantification of immunofluorescence staining shown in (L) and (M). Underlying data for (K) and (N) are 
provided in S1 Data. Scale represents 50µm in Fig 2I, J, L, M. Lumen is indicated with an asterisk in A-B, E-
F, I-J and L-M. For all statistical analyses ns denotes not significant, * denotes p≤0.05, ** denotes p≤0.01 
and *** denotes p≤0.001. 
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Specific uptake of plasma fibronectin in the vessel wall 96 
 97 
Since FN is crucial for vascular development during embryogenesis [30], a much stronger phenotype was 98 
expected for the deletion of FN in the aortic wall during early postnatal development. To exclude the 99 
possibility that these minor phenotypes in cFN iKO mice were potentially a consequence of incomplete 100 
deletion of cFN in the aortic media layer, we immunostained aortic sections using a cFN specific antibody 101 
that recognizes the alternatively spliced EDA domain, which is absent in pFN. This analysis clearly 102 
demonstrated that the EDA-containing cFN levels were very low as expected from an effective Fn deletion 103 
(see Fig 1B bottom panel) for the cFN iKO, as compared to the controls (Fig 2I-2K). However, staining with 104 
an anti-mouse FN antiserum that recognizes total FN (pFN and cFN), surprisingly revealed the presence of 105 
FN in the aortic media of the tamoxifen-induced cFN iKO, similar to the control (Fig 2L-N). This data led to 106 
the hypothesis that pFN from blood can transfer to the aortic wall, which in turn rescues a potential severe 107 
phenotype upon cFN deletion in the cFN iKO mice. 108 
 109 
To test this hypothesis, exogenous pFN labeled with a fluorophore (Oyster-680), was injected 110 
intraperitoneally daily from P8-P10 into tamoxifen-treated (P1-P3) control and cFN iKO mice, and mice 111 
were sacrificed and analyzed at P11. A strong fluorescent red signal in the ascending as well as in the 112 
descending aorta of both the control (Fig 3A and 3C) and cFN iKO mice (Fig 3B and 3D) demonstrated an 113 
efficient transfer of Oyster-680 labeled pFN into the vessel wall. Within the vessel wall, the Oyster-680 114 
labelled pFN localized to the elastic fibers (merged images in Fig 3A-3D), which were visualized label-free 115 
by detection of the elastin autofluorescence. To test if the transfer of intraperitoneally injected pFN to 116 
the vessel wall is specific for pFN, an Oyster-680 labelled 250kDa polysaccharide dextran (similar 117 
molecular mass as a pFN monomer) was injected in an identical regimen as used for the fluorophore-118 
labeled pFN. Contrary to the findings with injected pFN, no labeled dextran was observed in the aortic 119 
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media of ascending and descending aortae of control (Fig 3E and 3G) and cFN iKO (Fig 3F and 3H) mice. 120 
As an additional control to exclude the possibility of vascular leakiness, injected Oyster-680 alone did also 121 
not transfer into the vessel wall (Fig 3I-3L), despite a much smaller molecular mass (~2 kDa) compared to 122 
pFN. These results clearly show that pFN efficiently translocates to the aortic wall in the absence of 123 
vascular leakiness. 124 
 
Fig 3: Specific uptake of plasma fibronectin in the aortic vascular wall.  
pFN or mass-matched dextran was labelled with Oyster-680 (2-3 fluorescent molecules per molecule of 
pFN or dextran) and injected intraperitoneally from P8-P10 into tamoxifen-injected (P1-3) control mice and 
cFN iKO mice. Oyster-680 alone was used as a control. All mice were dissected on P11. Ascending and 
descending aortic walls were analyzed by immunofluorescence for elastic lamellae autofluorescence 
(green signal) and for Oyster-680 fluorescence (red signal). Representative analyses of aortic cross-sections 
from mice injected with fluorescently labelled pFN (A-D), dextran (E-H), and Oyster-680 (I-L) are shown. 
Note that Oyster-680 fluorescence can be detected only in the media of control and cFN iKO mice injected 
with fluorescent pFN, but not in the media of mice injected with fluorescent dextran, or Oyster-680 alone. 
The Oyster-680 labeled pFN colocalized with the elastic lamellae (see Merged in Fig 3A-D) (n=3-7 for A-L). 
Lumen is indicated with an asterisk in A-L. 
 
 
Deletion of plasma fibronectin does not affect the vascular wall 125 
 126 
To assess if pFN then plays a more important role in maintaining the cellular and matrix integrity of the 127 
vasculature, we generated pFN KO mice by crossing the Fn(fl/fl) mice with transgenic mice expressing the 128 
Cre recombinase under the control of the albumin promoter (Alb-Cre) active in hepatocytes [32,47], the 129 
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exclusive site for pFN synthesis (Fig 4A). The Alb-Cre/+ strain has been used successfully by others to 130 
generate liver-specific knockout mice [32,47,48]. The resulting Fn(fl/fl); Alb-Cre/+ strain lacks expression 131 
of pFN from P3 onwards [49], and the absence was confirmed by immunoblotting of plasma obtained 132 
from pFN KO and control mice at P30 (Fig 4B). No gross or histological phenotypes were observed in the 133 
aorta of pFN KO mice which would affect cellular or matrix integrity of the vessel wall (S2 Fig). These 134 
results together with the observation of pFN transfer into the vascular wall suggested that pFN has an 135 
important role in safeguarding the vasculature in the absence of cFN, however pFN is not needed for 136 
vascular integrity and function in the presence of cFN. 137 
 
Fig 4: Generation and analysis of pFN KO and dKO mice.  
A) pFN KO were generated by breeding Fn(fl/fl) mice with Alb-Cre/+ transgenic mice in several breeding 
rounds. B) Immunoblot for FN using mouse plasma isolated from control and pFN KO mice confirmed the 
absence of pFN in pFN KO mice (arrow). All mice were 30 d old at the time of blood collection (n=10). C) 
Generation of dKO mice by breeding Fn(fl/fl); Sma-Cre-ERT2/+ with Fn(fl/fl); Alb-Cre/+ mice. After injection 
with tamoxifen from P1-P3, the dKO mice lack total pFN and cFN secreted by SMCs. D) Hemorrhages in the 
thoracic cavity of dead dKO mice (P3 and P5), suggest a vascular cause of lethality (left and middle panel). 
The age-matched control pFN KO mice (found dead) do not show this phenotype (right panel). Animals of 
each group are shown in the top panel at 3× and in the botom panel at 4.5× magnification. Scale bars 
represent 1 mm. E and F) Representative immunostained images of aortic walls from P1-P3 tamoxifen-
injected control mice and dKO mice at P8 with antibodies against total FN (pFN and cFN) (E) and against 
EDA FN (specific for cFN) n=4 (F). Blue staining represents nuclei counter staining with DAPI. Quantification 
of the red FN signals is shown at the bottom of each figure and the underlying data are provided in S1 
Data. Note the significantly reduced levels of both, total FN and EDA FN in the media (arrowheads). Lumen 
is indicated with an asterisk and scale bar represents 50 µm in (E) and (F). 
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Double knockout of cFN in SMC and pFN causes postnatal lethality  138 
 139 
To further study the role of pFN and its functional interaction with cFN in the vasculature, we produced 140 
dKO mice deficient in pFN and cFN with the Fn(fl/fl); Sma-Cre-ERT2/+; Alb-Cre/+ genotype (Fig 4C). These 141 
mice lack pFN from P3 onwards and is additionally inducible by tamoxifen to delete cFN in α-SMA 142 
expressing tissues. When both, pFN and cFN, are deleted in the tamoxifen-injected dKO (P1-P3 tamoxifen 143 
injection), the mice die postnatally between P3 and P20 (median age of death P11.5). The Mendelian ratio 144 
was significantly reduced from the expected 25% to 4.23% by P30 (Table 1). Necropsy of dead dKO mice 145 
showed hemorrhages in the thoracic cavity (Fig 4D), indicating a severe phenotype in the vasculature due 146 
to combined loss of pFN and cFN in SMCs. Absence of any phenotypes in non-tamoxifen injected Fn(fl/fl); 147 
Sma-Cre-ERT2/+; Alb-Cre/+ mice eliminated the possibility of Cre toxicity. These mice had a normal life 148 
span and were used as breeders to maintain the mouse colony. Tamoxifen injected Cre-negative Fn(fl/fl) 149 
mice also survived normally demonstrating the absence of tamoxifen side effects. All other analyses 150 
throughout this study were performed on mice dissected immediately after cardiac perfusion to optimally 151 
preserve the tissue structure. Immunostaining on dissected dKO aortic wall tissues using a FN antibody 152 
that recognizes both isoforms showed a complete absence of pFN and cFN in the media layer as compared 153 
to the control (Fig 4E; triangles). Similarly, the immunostaining with an EDA-specific antibody confirmed 154 
an effective deletion of cFN in the dKO (Fig 4F; triangles). These results validated that both, pFN and cFN, 155 
are normally present in the aortic wall. The postnatal lethality observed in the dKO suggested that at least 156 
one of the two FN isoforms is required for maintaining vessel wall integrity and function.157 
  158 
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Table 1 Genotype and survival analysis of Fn knockout mice. 
 
 
a All mice (control, dKO, cFN iKO, and pFN KO) were injected with 0.1mg of tamoxifen/day from P1-P3. 
b Statistical analysis using the chi-square test (see Materials and Methods) 
c indicates a significant p-value 
Total mice analyzed = 71 
Total number of mice found dead before P30 = 18  
Genotype Control a 
Fn(fl/fl) 
dKO a 
Fn(fl/fl); Sma-Cre-
ERT2/+; Alb-Cre/+ 
cFN iKO a 
Fn(fl/fl); Sma-Cre-
ERT2/+ 
pFN KO a 
Fn(fl/fl); Alb-Cre/+ 
Calculated number and 
percentage of  mice 
expected at P30 
17.75 
(25%) 
17.75 
(25%) 
17.75 
(25%) 
17.75 
(25%) 
Mice alive at P30 
(Number and 
percentage) 
17 
(23.94%) 
3 
(4.23%) 
18 
(25.35%) 
15 
(21.13%) 
P-values for the 
difference observed 
from Mendelian ratiosb 
P>0.9 P<0.001c P>0.9 P>0.5 
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Fibronectin isoforms are important for maintaining cellular and matrix integrity of the vasculature 159 
 160 
We further investigated the dKO mice for the consequences of complete FN deficiency on aortic wall 161 
development in the early postnatal period. We choose P8 for this analysis, because most dKO mice survive 162 
until this time point (median age of death P11.5). To determine cell integrity, we stained aortic cross 163 
sections from all four tamoxifen-injected mouse strains with hematoxylin and eosin. SMCs in the aortic 164 
walls from dKO mice appeared to be disorganized as compared to circumferentially aligned cells in the 165 
control aortic sections (Fig 5A; triangles). Frequently, but not always, we observed thinning of the aortic 166 
wall in the dKOs as compared to the other strains analyzed. For a more detailed analysis, we performed 167 
transmission electron microscopy on aortic sections. The tunica media of dKO mice appeared disorganized 168 
with curled and irregular elastic lamellae (Fig 5B; S3 Fig; yellow triangles) and irregular shaped cell nuclei 169 
(Fig 5B; S3 Fig; red triangles) compared to control and single KO mice.  170 
 
Fig 5: Histological analysis of dKO by bright-field and transmission electron microscopy 
All mice were treated with tamoxifen from P1-P3 and the analysis was performed at P8. A) Hematoxylin 
and eosin stained cross sections of descending aorta prepared from control, dKO, cFN iKO and pFN KO mice 
as indicated. Note the disorganized cells (purple nuclei; black triangles) in the dKO as compared to the 
control. B) Transmission electron microscopic analysis of cross sections of descending aorta from control, 
dKO, cFN iKO and pFN KO mice. Note that the dKO aorta showed a disorganized tunica media as compared 
to the other strains analyzed. Curly disorganized elastic lamellae (yellow triangles) and irregular shaped 
SMC nuclei (red triangles) are discernible. Scale bar represents 10µm and asterisk (*) denotes aortic lumen. 
 
The affected elastic lamellae in the dKO led us to further investigate the consequences of Fn deletion on 171 
matrix integrity of the vascular wall, with a focus on ECM proteins important for elastogenesis. We 172 
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analyzed FBN-1 in the vessel walls of the KO mice, because it constitutes the backbone of microfibrils [50], 173 
which serve as a scaffold for elastin deposition and it is dependent on FN in cell culture studies [20,21]. 174 
Immunostaining clearly showed a reduction of FBN-1 in both the single KOs (cFN iKO and the pFN KO) and 175 
the dKO, as compared to the control, demonstrating that both pFN and cFN contribute to the 176 
deposition/assembly of FBN-1 in vivo (Fig 6A). Quantitative analysis revealed that the levels of 177 
deposited/assembled FBN-1 are lowest in the dKO and that cFN supports more FBN-1 178 
deposition/assembly than pFN (Fig 6E). pFN and cFN were similarly important for the deposition/assembly 179 
of FBLN-4, albeit it was reduced to the same level in all strains. (Fig 6B and 6E). For LTBP-4, which is also 180 
known to be dependent on FN for its assembly and is important in elastogenesis [25,51], cFN was 181 
important for its deposition/assembly but not pFN (Fig 6C and 6E). To determine if loss of FN affects 182 
tropoelastin deposition, either directly or indirectly by affecting other ECM proteins, sections were 183 
immunostained with a tropoelastin antibody and mature elastic lamellae were visualized by 184 
autofluorescence in aortic sections of all mouse strains analyzed. Even though the mature elastic lamellae 185 
appeared relatively normal at this magnification (whereas electron microscopy shows disorganized elastic 186 
lamellae in Fig 5B and S3 Fig), immunostaining with tropoelastin antibody was much reduced in sections 187 
from cFN iKO and dKO mice, compared to the control and the pFN KO mice (Fig 6D and 6E). Altogether 188 
these data suggest a role of cFN in new tropoelastin deposition and in elastin assembly in vivo. To analyze 189 
if this tropoelastin reduction affects the total elastin deposited in the aorta, we biochemically determined 190 
the elastin content and cross-links after NaOH extraction of P8 aortae. Surprisingly, the elastin per total 191 
protein was significantly reduced in dKO mice, whereas no significant changes occurred in the cFN iKO 192 
and pFN KO mice as compared to the control (Fig 6F). The crosslinks desmosine and isodesmosine per 193 
total elastin content and their ratio were not altered between the mouse strains (Fig 6F). mRNA 194 
expression analysis of the analyzed ECM components using qPCR demonstrated elevated Fbn1 mRNA 195 
levels in pFN KO aortae, which might represent a mechanism of the tissue to rescue reduced FBN-1 196 
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deposition/assembly (S4 Fig). mRNA expression of Fbln4, Ltbp4 and Eln was not altered, demonstrating 197 
that FN isoforms exclusively impact the deposition/assembly of these proteins (S4 Fig). In summary, these 198 
data show that the complete loss of FN impacts early postnatal vascular development by affecting both 199 
cellular and matrix integrity of the vessel wall. The results also demonstrate for the first time that FN is 200 
important for the deposition of various elastogenic proteins in vivo and its isoforms have both common 201 
and distinct roles in the organization of elastogenic proteins in the aortic media.  202 
 
Fig 6: Role of FNs in aortic vessel wall ECM organization.  
Descending aortic wall sections of tamoxifen-injected control, dKO, single cFN iKO, and single pFN KO mice 
were analyzed at P8 by indirect immunofluorescence. Shown are representative images stained with 
antibodies against (A) FBN-1, (B) FBLN-4, (C) LTBP-4 and (D) Tropoelastin either alone (left panels) or 
merged with elastic fibers (visualized through autofluorescence) (right panels). E) Quantification of the 
relative mean intensity of the red signals in immunostained sections shown in A-D. Note that FBN-1 and 
FBLN-4 is reduced in the dKO as well as in the single cFN iKO and pFN KO as compared to the control, but 
only FBN-1 is significantly lower in the dKO as compared to the single KOs (A, B, E). LTBP-4 and tropoelastin 
immunostaining is reduced in the dKO and cFN iKO but not in pFN KO (C, D, E). Scale bar represents 20µm 
in Fig 6 A-D (n=3). Underlying data are provided in S1 Data.  F) Biochemical analysis was performed after 
NaOH extraction of aortae of all four mouse strains dissected at P8 (n=6). Note the decrease in elastin 
content without changes in elastin crosslinks in the dKO. Underlying data are provided in S1 Data.  Isodes, 
isodesmosine; Des, desmosine. * represents a p-value of ≤0.05, ** a p-value of  ≤0.01 and *** a p-value of  
≤0.001 in Fig 6E (two sample t-test) and F (one way ANOVA).  
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Similar roles of FN isoforms in ECM assembly  203 
 204 
The in vivo data indicated a functional relationship between pFN and cFN in matrix organization. To further 205 
study how the two isoforms interact with each other and contribute to its own assembly and deposition 206 
of other ECM proteins, a cellular model was developed. Vascular SMCs from Fn(fl/fl); Sma-Cre-ERT2/+ 207 
mouse aortae were treated with 4-hydroxytamoxifen for 3 days to induce cFN deletion. As controls, the 208 
cells were treated with ethanol (solvent of 4-hydroxytamoxifen). RT-PCR showed an effective deletion of 209 
Fn upon treatment with 4-hydroxytamoxifen as compared to the ethanol-treated control (Fig 7A). 210 
Immunoblotting of the serum-free conditioned medium collected from these cells, using specific FN 211 
antibodies showed an effective reduction of cFN in tamoxifen treated cells, compared to the ethanol-212 
treated cells (Fig 7B). Indirect immunofluorescence of SMCs cultivated in FN-depleted medium 213 
additionally demonstrated the absence of a FN network in 4-hydroxytamoxifen-treated cells versus a fully 214 
developed network in the ethanol-treated cells (Fig 7C). This result was further confirmed by the absence 215 
of fibronectin in deoxycholate (DOC) soluble and insoluble fractions extracted from 4-hydroxytamoxifen-216 
treated cells (S5 Fig).  Deletion of Fn prevented the assembly of FBN-1 (Fig 7D), and of FBLN-4 (Fig 7E). 217 
This experimental model was then expanded, by combining it with plasma obtained from control and pFN 218 
KO mice, to test the functional relationship between pFN and cFN in matrix organization. The cells were 219 
tested under the following conditions: 1) cFN+/pFN+; 2) cFN+/pFN–; 3) cFN–/pFN+; and 4) cFN–/pFN– (for 220 
details see Materials and Methods). Indirect immunofluorescence under these conditions and fiber length 221 
quantification showed that either cFN or pFN alone (Fig 7F; arrowheads) can form fibers, corroborating 222 
the functional in vivo data which showed that either one of the individual FN isoforms is sufficient for 223 
maintaining the vascular integrity. FN assembly is also enhanced in the presence of both isoforms (Fig 7F; 224 
arrows and S1 Table), suggesting that the two isoforms can assemble together to form matrix fibers. 225 
Similarly, each of the two FN isoforms supported the formation of FBN-1 fibers (Fig 7G; arrowheads), as 226 
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well as the deposition of FBLN-4 (Fig 7H; arrowheads). cFN contributed more than pFN in supporting FBN-227 
1 fibers but equal for FBLN-4 deposition, corresponding with the in vivo data (Fig 6A , B and E). The results 228 
for LTBP-4 (Fig 7I; arrowheads) also correlated with the in vivo role of cFN in promoting LTBP-4 assembly 229 
and showed very little contribution, of pFN. But it is important to note that because of the selected sources 230 
of FN isoforms (mouse plasma for pFN and SMCs for cFN) to closely mimic the in vivo situation, the actual 231 
amounts of individual isoforms could be different. This could contribute to the differences observed 232 
between cFN containing condition (cFN+/pFN–) and the condition with pFN only (cFN–/pFN+). 233 
Tropoelastin and elastic fibers could not be detected in this cell system. For all proteins tested, the 234 
presence of both, pFN and cFN mediated longer total fiber lengths and more junctions compared to the 235 
presence of only one FN isoform, suggesting the two isoforms of FN can contribute together in self-236 
assembly and in guiding the assembly/deposition of other matrix proteins  (Fig 7, right panel; S1 Table).  237 
 
Fig 7: Similar role of FN isoforms in the assembly of elastic fiber related proteins.  
Vascular SMCs were isolated from Fn(fl/fl); Sma-Cre-ERT2/+ mouse aortae and grown in medium depleted 
of pFN. Cells were treated with 4-hydroxytamoxifen (4-OH Tamox) for 3d to induce the deletion of cFN, 
and compared to ethanol-treated controls (EtOH). A) RT-PCR demonstrates at mRNA level an effective 
deletion of Fn upon treatment with 4-hydroxytamoxifen compared to the ethanol control (219 bp). Gapdh 
was used as a control (202 bp) (n=3). B) Immunoblot of FN using conditioned cell culture medium (24h) 
showed effective FN deletion on the protein level when cells were treated with 4-hydroxytamoxifen (n=4). 
R indicates reducing conditions with 20mM Dithiothreitol and NR represents non-reducing conditions. The 
three arrows indicate monomer, dimer and higher molecular weight species of FN precipitates from the 
conditioned medium. C-E) 4-hydroxytamoxifen and ethanol-treated SMC were stained after 7d in culture 
by indirect immunofluorescence against (C) FN, (D) FBN-1, and (E) FBLN-4. Note the absence of FBN-1 and 
FBLN-4 networks when FN is deleted. Scale bar for C-E is 100 µm (n=3). Underlying data are provided in S1 
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Data.  F-I) To test the role of pFN and cFN in facilitating self-assembly and that of FBN-1, FBLN-4, and LTBP-
4 in conditions replicating the mouse models, four cell culture conditions were generated (see Materials 
and Methods for details): 1) cFN+/pFN+; 2) cFN+/pFN−; 3) cFN−/pFN+; and 4) cFN−/pFN−. Indirect 
immunofluorescence analyses were performed after 5d of cell growth with antibodies against (F) FN, (G) 
FBN-1, (H) FBLN-4, and (I) LTBP-4. Note that in the presence of pFN and cFN individually short immature 
fibers develop (arrowheads), whereas the presence of both FN isoforms support enhanced FN self-
assembly as well as the assembly and/or deposition of FBN-1, FBLN-4 and LTBP-4 (arrows). The graphs 
show a histogram distribution of branch lengths for the cFN+/pFN+, cFN+/pFN−, and cFN−/pFN+ samples. 
No measureable fibers were present in the cFN−/pFN− samples. Underlying data are provided in S1 Data.  
Total fiber lengths and junction numbers are listed in S1 Table. The scale bar for F-I indicates 50µm (n=4). 
 
 
Distinct roles of FN isoforms in ECM assembly 238 
 239 
To analyze if they are actually differences between pFN and cFN in fiber formation and in guiding the 240 
assembly of other ECM proteins, another cell model was developed which could assess the effects of equal 241 
amounts of purified cFN and pFN, unlike the SMC cell culture model where cFN was produced by the cells 242 
and pFN was present in the mouse plasma added.  243 
Mouse embryonic fibroblasts from Fn null embryos are well known to assemble exogenously provided FN 244 
[16]. In a culture medium devoid of pFN, these cells grow under FN-free conditions. The absence of any 245 
FN fibers in this cell system was validated by indirect immunofluorescence (Fig 8A; TBS control). Equal 246 
amounts (25 µg/ml) of soluble purified pFN or cFN was added into the medium and the quality and 247 
quantity of fibers were analyzed. The fibers formed were clearly different between the two FN isoforms 248 
(Fig 8A). cFN formed more mature and elongated fibers (Fig 8A; arrows), whereas pFN formed less fibers 249 
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and the fibers were shorter in length (Fig 8A; arrowheads). Similar consequences were observed for both 250 
FN isoforms in guiding FBN-1 (Fig 8B), and FBLN-4 (Fig 8C). For LTBP-4, cFN supported 251 
assembly/deposition, but pFN could barely support any fiber formation, corresponding well with the in 252 
vivo data (Fig 8D). For all proteins tested, cFN mediated longer total fiber lengths and more fiber junctions 253 
(Fig 8, right panel; S2 Table). These results demonstrate that pFN and cFN assemble differently, and 254 
translate these differences onto dependent downstream ECM formation and deposition. Taken together, 255 
the data from the two cell culture models and the in vivo results suggest that there are some similar 256 
functions but other different role that cFN and pFN play in self-assembling and in supporting the assembly 257 
of other ECM proteins. 258 
 
Fig 8: Distinct roles of FN isoforms in guiding ECM assembly.  
Mouse embryonic fibroblasts from Fn null embryos were grown in a pFN-depleted cell culture medium. 
Equal amounts of purified human cFN (25µg/ml) or human pFN (25µg/ml), or a TBS control was added to 
the medium at the time of cell seeding. Indirect immunofluorescence was performed after 8d cell growth 
with antibodies against (A) FN, (B) FBN-1, (C) FBLN-4, and (D) LTBP-4. Note the differences in the quality 
and the quantity of the analyzed fiber systems. cFN supports assembly of longer and more mature fibers 
(arrows), while pFN forms and supports short and thin fibers (arrowheads). The graphs show a histogram 
distribution of branch lengths for the cFN added and pFN added samples. No measureable fibers were 
present in the TBS samples. Underlying data are provided in S1 Data. Total fiber lengths and junction 
numbers are listed in S2 Table. The scale bar indicates 50µm for all images (n=3).  
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Discussion 259 
 260 
FN is a critical player in vascular biology with essential roles in embryonic development, in various 261 
cardiovascular diseases and in pathologies where vascular development is a key process such as in tumor 262 
progression. However, virtually nothing is known about the role of FN and its isoforms during physiological 263 
postnatal vascular development. Here, we report that deficiency of both, hepatocyte-derived pFN and 264 
SMC-derived cFN, arrests early postnatal aortic development, whereas either one FN isoform is sufficient 265 
to support vascular maturation at this developmental stage. We have identified a novel function of pFN 266 
in which it represents a safeguard in maintaining blood vessel wall integrity by translocating into the vessel 267 
wall. This is also the first report to show, in vivo, the role of FN as a “master organizer” for ECM assembly 268 
and to establish that both pFN and cFN have a critical function in vascular wall protein 269 
assembly/deposition. 270 
 271 
From the initial global knockout, it became clear that FN has a critical role in the development and 272 
homeostasis of the major blood vessels, as the mice die during embryogenesis around E9.5 with a variety 273 
of phenotypes including defects in blood vessel development [30]. Deletion of both alternatively spliced 274 
EDA and EDB exons (present only in cFN) from the Fn gene led to embryonic lethality by E10.5, displaying 275 
also multiple cardiovascular defects, including vascular hemorrhage, failure of remodeling embryonic and 276 
yolk sac vasculature, and defective placental angiogenesis [31]. While cFN is essential for cardiovascular 277 
development during embryogenesis, we established from our study that postnatal conditional deletion of 278 
cFN in SMCs induced at P1-P3, only results in minor aortic phenotypes not affecting the life span of the 279 
mice as pFN is able to rescue the functions. Similarly, postnatal deletion of pFN around P3 in our study, 280 
did not result in any obvious aortic phenotype, because SMC-derived cFN is sufficient to maintain the 281 
vascular integrity. Therefore, both SMC-derived cFN and pFN are thus individually dispensable for the 282 
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postnatal development and homeostasis of the thoracic aorta. However, the deletion of both FNs around 283 
P3 resulted in death of most (>80%) dKO mice until P30. These data demonstrate that at least one of the 284 
FNs is required for the continued postnatal development and stability of the thoracic aorta, and that pFN 285 
can compensate for the loss of SMC-derived cFN. However, Murphy et al. reported that when FN was 286 
deleted globally (absence of both, cFN and pFN) in adult mice, no vascular phenotype was observed, 287 
except when the mice were challenged by disturbed blood flow in the carotid arteries resulting in 288 
enlargement of the aorta and hemorrhage [52]. The dependency on at least one, SMC-derived cFN or pFN, 289 
during early postnatal aortic development is likely due to the requirement of deposition of new ECM as 290 
the aorta grows and matures within the first 4 postnatal weeks [53]. It is known that new elastin 291 
deposition during this phase occurs at the fenestrations in the elastic lamellae [54]. As the dKO mice die 292 
during this expansion phase, it is possible that FNs support a role in the deposition of new elastin at these 293 
fenestrations. This assumption is further supported by i) ultrastructural tissue analysis which showed 294 
irregular elastic lamellae, and ii) biochemical data that showed reduced newly deposited elastin at P8 in 295 
the dKO mice. Taken together, these ECM deficiencies in the aortic media of the dKO mice are likely the 296 
cause for the postnatal lethality of these mice. 297 
 298 
cFN iKO mice showed similar matrix defects in the tunica media compared to dKO mice at P8 when 299 
analyzed by immunofluorescence (Fig 6). However, at later time points (8 months) no deficiencies in 300 
matrix components were observed in the cFN iKO as compared to control mice (S1 Fig). This indicates that 301 
it takes likely somewhat longer than P8 (5 days after tamoxifen injection) for pFN to fully rescue the 302 
functions of the deleted SMC-derived cFN, so that the cFN iKO mice develop and survive normally. Our 303 
cell culture data also support this hypothesis as pFN can take over the functions of cFN but only partially 304 
when analyzed at the same time point (Fig 8).   305 
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It was shown in cell culture studies that pFN and cFN have similar, but not identical cellular and 306 
biochemical functions. For example the FN isoforms were equally effective in promoting cell spreading 307 
and mediating cell attachment to collagen and gelatin substrates [55,56]. On the other hand, EDA/EDB 308 
containing cFN incorporated more efficiently into existing fibers compared to pFN [57]. We have identified 309 
qualitative and quantitative differences in the FN and FN-dependent fiber systems between the two FN 310 
isoforms. cFN formed and supported extended fibers, while pFN formed and guided shorter fibers. This is 311 
potentially the result of differential crosslinking of the two isoforms by transglutaminases, where cFN 312 
forms a very high molecular weight complex but does not form the intermediate multimers observed in 313 
pFN crosslinking [58]. In addition, different transglutaminases act on the two FN isoforms [59].  314 
 315 
Our in vivo and cell culture data also provide new insights into the functional relationship of pFN and cFN 316 
where the two isoforms interact to self-assemble and support the deposition of elastogenic ECM proteins. 317 
We and others have previously shown in cell culture that the assembly of fibrillins are strictly dependent 318 
on FN fibers [20,21]. It is thought that small units of fibrillin-containing microfibrils are transferred to FN 319 
fibers for further elongation and maturation [60]. Here, we demonstrate in cell culture and in vivo that 320 
both, pFN and cFN, support the assembly of FBN-1 and/or the deposition of microfibrils onto the elastic 321 
laminae, with greater contribution from cFN. We also identified a FN dependency for FBLN-4 322 
assembly/deposition in cell culture and in vivo, which extends the list of FN-depending ECM fiber systems. 323 
It is currently not known, however, whether FBLN-4 interacts directly with FN or through other mediators, 324 
potentially including FBN-1. Two other critical elastogenic proteins, LTBP-4 and tropoelastin, showed a 325 
differential pattern, both requiring cFN for their assembly/deposition in vivo (and in cell culture for LTBP-326 
4), whereas pFN was not required. The common aspect for both proteins, is that their assembly is 327 
hierarchically dependent on the presence of FBN-1 and microfibrils [26,61], and thus only indirectly on 328 
the presence of FN fibers. One interpretation of these data is that cFN has additional functional or 329 
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stabilizing consequences (not shared by pFN) on microfibrils that enable them to promote LTBP-4 and 330 
tropoelastin assembly. The data for FBN-1 and LTBP-4 are in contrast to what was found in tumors where 331 
nearly complete FN deletion did not affect the assembly/deposition of these proteins [62]. However, in 332 
that study, FN deletion was induced much later (5–6 weeks) than in our study followed by tumor analysis 333 
at 12-13 weeks. It is possible that the dependency of FBN-1 and LTBP-4 on FN is primarily required in the 334 
early postnatal phase when blood vessels still undergo intensive remodelling and growth, or, alternatively, 335 
it is possible that this dependency is tissue specific (aorta versus tumor).   336 
  337 
The concept of translocation of pFN from blood into tissues is known for several organs including liver, 338 
spleen, brain, and bone [48,63-65]. Here, we provide novel data showing the function of the translocated 339 
pFN in the vascular wall of the aorta. Translocation and accumulation of pFN in the tunica media is not 340 
required for normal postnatal development and homeostasis of the aorta evidenced by the absence of a 341 
phenotype in the pFN KO. However, in the absence of SMC-derived cFN in the tunica media, the 342 
translocated pFN is able to completely rescue a fetal phenotype (obvious in the dKO), leading to the 343 
concept of a critical safeguard function of pFN in maintaining vascular stability and health. This may help 344 
explain vascular manifestations in a variety of disorders associated with defective cFN expression 345 
including atherosclerosis [36], myocardial infarction [37], Sturge-Weber Syndrome [38], and Ehlers-Danlos 346 
syndrome Type X [39], or altered circulating pFN levels such as coronary heart disease [40,41], and 347 
ischemic heart disease [42].  348 
 349 
For the translocation of pFN to the vascular wall, we have excluded a passive diffusion through potentially 350 
leaky endothelial cell layer, as both 250 kDa dextran and the 2 kDa fluorophore do not enter the tunica 351 
media. Transcytosis, the transport of molecules across cells through coupled endocytosis and exocytosis 352 
transport pathways, is a hallmark of endothelial cells, which is frequently mediated through caveolae [66]. 353 
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Active transcytosis of albumin through endothelial cells for example has been shown to be dependent on 354 
caveolae [67,68]. While it is not known whether FN uses this pathway, FN can be turned over through 355 
integrin β1-mediated (e.g. α5β1) endocytosis regulated by caveolin-1 [69,70]. Thus, it is possible that pFN 356 
transcytosis follows a similar transport mechanism. 357 
 358 
In summary, this study illuminates the critical role of FN isoforms in postnatal vascular development. It 359 
reveals a novel function of pFN where it transfers to the vessel walls to safeguard the role of cFN. The two 360 
isoforms play important differential and similar functions in maintaining the integrity and matrix stability 361 
of the vasculature.  362 
27 
 
Materials and Methods 363 
 364 
Ethics statement 365 
All animal studies strictly followed the guidelines imposed by the Canadian Council on Animal Care and 366 
were approved by the McGill University Animal Care Committee (protocol 2010-5893). Mice were 367 
euthanized by an anesthetic overdose using a ketamine/xylazine/acepromazine cocktail followed by 368 
cardiac perfusion. 369 
 370 
Mouse models 371 
Fn(fl/fl) mice were generated as previously described [32], and were used as controls throughout the 372 
study unless mentioned otherwise. Sma-Cre-ERT2/+ mice were a generous gift from Drs. Pierre Chambon 373 
and Daniel Metzger and generated as described [46]. Alb-Cre/+ (B6.Cg-Tg(Alb-cre)21Mgn/J; Stock 374 
No. 003574) and Rosa26(fl/fl) (B6.129S4-Gt(ROSA)26Sortm1Sor/J; Stock No. 003309) mice were 375 
purchased from the Jackson Laboratory. Inducible cFN iKO mice (Fn(fl/fl); Sma-Cre-ERT 2/+) were 376 
generated by crossing Fn(fl/fl)mice with Sma-Cre-ERT2/+ mice following several breeding rounds. 377 
pFN KO (Fn(fl/fl); Alb-Cre/+) mice were obtained by crossing Fn(fl/fl) with Alb-Cre/+ mice after 378 
several crossings. Generation of double knockout (dKO) (Fn(fl/fl);  Sma-Cre-ERT 2/+; Alb-379 
Cre/+) mice was achieved by breeding Fn(fl/fl); Sma-Cre-ERT2/+ with Fn(fl/fl); Alb-Cre/+ mice. 380 
Several breeding rounds were used to produce Reporter-Cre mice (Rosa26(fl/fl); Sma-Cre-ERT2/+) 381 
from Sma-Cre-ERT2/+ and Rosa26(fl/fl) mice. 382 
 383 
Tamoxifen injection 384 
To delete Fn (deleted region encompassing start codon, sequence for signal peptide and exon/intron 385 
border of exon 1) in SMCs of cFN iKO and dKO mice, and to induce β-galactosidase expression in the 386 
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Reporter-Cre mice, 0.1 mg of tamoxifen (Sigma) was injected intragastrically daily from P1-P3, using a 387 
2mg/mL tamoxifen solution in sunflower oil [71]. The same tamoxifen treatment regimen was followed 388 
for all the mouse strains analyzed with cFN iKO, dKO or Reporter-Cre (including control- Fn(fl/fl), pFN KO 389 
(Fn(fl/fl);Alb-Cre/+ and Reporter control (Rosa26(fl/fl)).  390 
 391 
Validation of cFN deletion 392 
To validate Fn deletion, reverse transcriptase polymerase chain reaction (RT-PCR) was performed using 393 
total RNA isolated from descending aorta of 8 days old mice using the Trizol method (Life Technologies). 394 
cDNA synthesis was achieved using SuperScript III kit (Invitrogen). A 219 bp Fn specific PCR product was 395 
amplified using Fn-sense 5’-CTGAACCAGCCTACAGATGAC-3’ and antisense 5’-CATTTTCTCCCTGCCGATCC-396 
3’ primers and compared to a 202 bp Gapdh specific PCR product, obtained with Gapdh-sense 5’-397 
GTTGCCATCAACGACCCCTTC-3’ and antisense 5’-ACTCCACGACATACTCAGCAC-3’ primers.  398 
 399 
Tissue staining procedures 400 
For the analysis of Cre recombinase activity, aortae were harvested from tamoxifen-injected Reporter-Cre 401 
(Rosa26(fl/fl); Sma-Cre-ERT2/+) and Reporter-control ( Rosa26(fl/fl)) mice and were embedded in OCT 402 
(Sakura Finetek). 8µm cryosections were stained using an established β-galactosidase staining protocol 403 
[72]. 404 
For histological and immunohistological staining procedures, mice were euthanized by an anesthetic 405 
overdose using a ketamine/xylazine/acepromazine cocktail. Mice were then cardiac-perfused with 10% 406 
neutral-buffered formalin and aortae were harvested. After an overnight incubation in 10% neutral 407 
buffered formalin, the tissues were dehydrated through an increasing ethanol gradient, and embedded 408 
in paraffin. 4µm sections were deparaffinized in CitriSolv (Decon Labs) and rehydrated with decreasing 409 
ethanol concentrations in H2O. The sections were stained with Hematoxylin and Eosin (general histology 410 
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and cell orientation), or Masson’s Trichrome Stain (collagen), or picrosirius red (collagen), or Hart’s elastin 411 
stain using standard procedures. For immunostaining, the sections were treated for antigen retrieval with 412 
10mM citric acid, 0.05% Tween 20 (pH 6) at 98°C followed by treatment with bacterial type XXIV 413 
proteinase (10 µg/ml; Sigma #P8038). The sections were then incubated with primary antibody 414 
(monoclonal anti-human smooth muscle α-actin (SMA) Clone 1A4 (Dako #M0851) at a 1:100 dilution and 415 
polyclonal anti-mouse fibrillin-1 C-terminal half (generated in the lab) at 1:300). The immunostaining 416 
procedure was performed using the Dako Envision+ System-HRP (AEC) staining system (Dako #K4004 and 417 
#K4008).  418 
For immunofluorescence staining procedures, the aortae were perfused as above, but only fixed in 419 
formalin for 1-2h. The tissues were then cryoprotected by incubating in a 30% sucrose solution and then 420 
embedded in OCT. 8µm cryosections were cut and hydrated in Tris-buffered saline (TBS), and blocked with 421 
2% delipidized bovine serum albumin. Primary antibodies were monoclonal anti-EDA FN (Abcam# AB6328; 422 
1:100), polyclonal rabbit anti-mouse FN (Millipore #AB2033; 1:500 diluted), polyclonal rabbit anti-human 423 
FBLN-4 [73], 1:500 diluted, polyclonal rabbit anti-mouse FBN-1 (generated in the lab; 1:3,000 diluted), 424 
polyclonal rabbit anti-mouse LTBP-4 (generated in the lab; 1:500 diluted), and polyclonal rabbit anti-425 
human elastin (Elastin Products Company #PR398; 1:500 diluted). Secondary antibodies were used at 426 
1:200 dilutions and included Cy5 AffiniPure Goat anti-Rabbit IgG (H+L) and Cy5 AffiniPure Goat anti-Mouse 427 
IgG (H+L) (Jackson Laboratories). Cell nuclei were counter-stained with 4',6-diamidino-2-phenylindole, 428 
dihydrochloride (DAPI) at a concentration of 2.5µg/ml.  429 
 430 
pFN and dextran translocation experiments 431 
pFN and dextran translocation experiments were performed with litters injected with tamoxifen (P1-P3) 432 
to generate cFN iKOs and controls (Fn(fl/fl)). Human pFN (Millipore #FC010) or 250kDa amino dextran 433 
(Fina Biosolutions #AD 250 X 100) were covalently coupled to the water soluble activated fluorophore 434 
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Oyster-680 N-hydroxysuccinimide ester (Boca Scientific) in 100mM NaHCO3, 500mM NaCl, pH 8.4. Oyster-435 
680 emits light at 693 nm, which does not overlap with the known autofluorescence of elastic lamellae in 436 
the aorta. Unbound fluorophore was removed by dialysis against the coupling buffer, and the degree of 437 
labeling was calculated to be 3-4 molecules Oyster-680 per molecule of pFN or dextran. The labeled pFN 438 
or dextran was injected in mice intraperitoneally from P8-P10 (0.13mg per mouse per day) using an 439 
established protocol [48,74]. TBS-deactivated Oyster-680 alone used at the same molar concentration 440 
served as control. 18h after the last injection, the mice were dissected and tissues harvested after 441 
euthanasia following anesthetic overdose with a ketamine/xylazine/acepromazine cocktail. 8µm OCT-442 
embedded cryosections were analyzed with a Cy5 filter set. Elastin autofluorescence was analyzed using 443 
GFP filter set to visualize label-free the elastic lamellae. 444 
 445 
Analysis of pFN in blood 446 
Blood was collected by cardiac puncture from pFN KO and control (Fn(fl/fl)) mice following euthanasia. 447 
Plasma preparation was performed using EDTA-coated tubes (Sarstedt). 3µl aliquots of plasma were 448 
analyzed by standard Western blotting under reducing conditions. The polyclonal rabbit anti-mouse FN 449 
antiserum (Millipore #AB2033) was used 1:500 diluted as primary antibody with the 1:200 diluted 450 
Peroxidase-AffiniPure Goat Anti-Rabbit IgG (H+L) (Jackson Laboratories) as secondary antibody. 451 
 452 
Necropsy 453 
To investigate the cause of lethality in dKO mice, litters injected with tamoxifen (P1-P3) were monitored 454 
twice every day. Dead pups were found often for dKOs but occasionally we found dead pups from other 455 
tamoxifen injected strains, which were used as controls for the necropsy. Dead pups were fixed in 10% 456 
neutral buffered formalin (overnight) and washed twice in phosphate buffered saline to prevent post-457 
mortem changes. Necropsy was performed to visualize gross anatomy of the dead pups with a focus on 458 
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the aorta and thoracic cavity. Images were recorded using an AmScope dissection microscope (ZM-1TZ2-459 
FOR-GT-10M) equipped with a digital camera.   All other analyses throughout this study were performed 460 
on mice dissected immediately after cardiac perfusion to optimally preserve the tissue structure and avoid 461 
any post mortem changes. 462 
 463 
Transmission electron microscopy 464 
For transmission electron microscopic analysis, mice were euthanized by an anesthetic overdose with a 465 
ketamine/xylazine/acepromazine cocktail, followed by cardiac-perfusion with 3% glutaraldehyde in 0.1 M 466 
sodium cacodylate buffer (pH 7.4) (fixative). The aortae were then harvested and incubated in the fixative 467 
for overnight. This was followed by a post fixation step with 1% osmium tetraoxide + 1.5% aqueous 468 
potassium ferrocyanide. Aortae were then dehydrated with an increasing concentration of acetone 469 
followed by embedding in Epon. 90nm sections were transferred onto 200 mesh copper TEM grids and 470 
counterstained stained using 4% aqueous uranyl acetate and Reynold’s lead before imaging with an FEI 471 
Tecnai 12 BioTwin 120 kV transmission electron microscope. 472 
 473 
Biochemical protein analysis 474 
Thoracic aortae from all the four mouse strains at P8 (post tamoxifen injection) were extracted by 0.1N 475 
NaOH at 95°C for 45min. After centrifugation, the pellets containing insoluble elastin were subjected to 476 
hydrolysis and amino acid analysis using a three buffer gradient system and post column ninhydrin 477 
derivatization. The content of elastin cross-links (isodesmosine (Isodes) and desmosine (Des)) were 478 
analyzed in an aliquot of the NaOH-insoluble fraction containing elastin after CF-11 preclearance by amino 479 
acid analysis (leucine equivalence factors IDES: 3.4; DES: 3.4). The amino acid composition of the NaOH-480 
insoluble protein fraction was typical for pure elastin [75]. 481 
 482 
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Quantitative PCR 483 
Descending aortae were harvested from tamoxifen-injected control, dKO, cFN iKO and pFN KO 484 
(littermates) at P8. Total RNA was isolated using the Trizol method (Life Technologies). RNA was reverse-485 
transcribed using ProtoScript II First Strand cDNA synthesis kit (New England Biolabs). A QuantStudio 5 486 
Real Time PCR System (Applied Biosystems) was used to perform the quantitative PCR using SYBR Select 487 
Master Mix (Applied Biosystems). Specific primers were used for all the genes analyzed. Gapdh was used 488 
as the control gene. Relative quantification of mRNA levels (fold change) was calculated using the 2-ΔΔCt 489 
method. Significance was determined using the two tail t-test. 490 
 491 
Analyses of cell cultures 492 
SMCs were isolated from the tunica media of aortae harvested from Fn(fl/fl); Sma-Cre-ERT2/+ mice using 493 
an established explant based method [76]. Cells were cultured in DMEM/F12 medium (Gibco) 494 
supplemented with 10% heat inactivated fetal bovine serum and 100µg/ml penicillin/streptomycin and 495 
2mM glutamine. Cells were treated with 1µM of activated 4-OH tamoxifen for 3d to induce the deletion 496 
of Fn (deleted region as described above). Ethanol, the solvent for 4-OH tamoxifen, was used as a control 497 
at a final concentration of 0.02% (same concentration as used for the 4-OH tamoxifen treatment). For 498 
experiments, cells were grown in medium containing fetal bovine serum depleted of pFN by gelatin 499 
sepharose chromatography [21]. Deletion of cFN was analyzed by RT-PCR from mRNA isolated from cells 500 
using RNeasy mRNA extraction kit (Qiagen). RT-PCR was performed as described above. Deletion was also 501 
analyzed at protein level by Western blotting with 15µl of conditioned medium (obtained after 24h) using 502 
1:500 diluted anti FN antibody (Millipore #AB2033). Indirect immunofluorescence was performed after 503 
7d with 70% methanol/30% acetone fixed and permeabilized cells. Goat serum diluted in phosphate 504 
buffered saline (1:10) was used for blocking. Primary antibodies were prepared in blocking buffer and 505 
included polyclonal rabbit anti-mouse FN (Millipore #AB2033 – 1:500 diluted), anti-mouse FBN-1 (1:500 506 
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diluted), anti-human FBLN-4 (1:500 diluted). Alexa Fluor 488 goat anti-rabbit IgG (H+L) (1:200 diluted) 507 
were used as secondary antibodies. Deoxycholate (DOC) extraction was performed using standard 508 
procedures as described in [77]. DOC soluble and insoluble fractions were analyzed by Western blotting 509 
using 1:500 diluted anti FN antibody (Millipore #AB2033). 510 
Experiments were designed to mimic the three knockout mouse models and the control in cell culture as 511 
follows. 4-OH tamoxifen and ethanol-treated cells were cultured in the presence of 10% mouse plasma 512 
prepared from either wild-type or from pFN KO mice. The combination used were: 1) cFN+/pFN+, Ethanol-513 
treated cells (cFN present) were grown in medium containing mouse plasma from control mice (pFN 514 
present); 2) cFN+/pFN–, Ethanol-treated cells (cFN present) were grown in medium containing mouse 515 
plasma from pFN KO mice (pFN absent); 3) cFN–/pFN+, 4-OH tamoxifen treated cells (cFN absent) were 516 
grown in medium containing mouse plasma from control mice (pFN present); 4) cFN–/pFN–, 4-OH 517 
tamoxifen treated cells (cFN absent) were grown in medium containing mouse plasma from pFN KO mice 518 
(pFN absent). After 5d, cells were fixed with 4% paraformaldehyde and immunofluorescence was 519 
performed as described above, additionally with primary LTBP-4 antibody (1:500 diluted) and secondary 520 
Cy5 AffiniPure Goat anti-Rabbit IgG (H+L) antibody (Jackson Laboratories, 1:200 diluted). No LTBP-4 fibers 521 
were observed in this setup. But when instead of using mouse plasma, 40µg/ml of purified soluble pFN 522 
was added to the system, LTBP-4 fibers formed. This could be due to factors present in the mouse plasma, 523 
which might affect LTBP-4 assembly. 524 
Mouse embryonic fibroblasts differentiated from Fn null mouse embryonic stem cells were prepared as 525 
described [78]. As for the SMCs, the Fn-/- embryonic fibroblasts (that do not produce cFN) were grown in 526 
pFN-depleted cell culture medium, providing an experimental fibroblast system without pFN and cFN. 527 
Affinity chromatography on immobilized gelatin was used to purify human pFN from plasma as described 528 
in detail [79], and cFN from human fibroblast conditioned medium as previously described [80].  12.5µg 529 
of purified pFN or cFN was added to 500µl of culture medium at the time of cell seeding. Cells were fixed 530 
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with 4% paraformaldehyde after an 8d culture period and analyzed by indirect immunofluorescence as 531 
outlined above. 532 
 533 
Light Microscopy Imaging 534 
An epifluorescence microscope (AxioImager M2; Zeiss) was used to capture all bright field and 535 
immunofluorescence images with an AxioCam ICc5 color camera or an Orca Flash 4.0 sCMOS gray scale 536 
camera, respectively. Gray scale immunofluorescence images were false colored using the Zen Pro 537 
software (Zeiss).  538 
 539 
Quantification Procedures 540 
Mean pixel intensity analysis of various fluorescent signals (EDA FN, Total FN, FBN-1, FBLN-4, LTBP-4, 541 
Tropoelastin) was performed with 8-bit TIFF images using the ImageJ software [81] on regions of the 542 
tunica media as described by others [52]. The mean pixel intensity of the background was deducted to 543 
produce the values used for plotting the graphs. The error bars in the graphs represent standard deviation.  544 
For collagen analysis, picrosirius red stained images of the aorta were obtained through fluorescence 545 
microscopy using a Zeiss HQ Texas Red filter set [82]. Mean pixel intensity, total intensity and area of 546 
collagen distribution analysis in the tunica media and tunica adventitia was performed using the ImageJ 547 
software as described above. Error bars represent standard deviation.  548 
Quantification of total fiber lengths and junction number of extracellular matrix fibers visualized by 549 
immunofluorescence was performed using the ImageJ distribution Fiji [83,84]. Color images were 550 
converted to 8-bit and threshold was set to best match the fiber appearance in the original image (same 551 
threshold for all the images comparing the same protein staining). This was followed by removing the 552 
noise using despeckle feature, followed by skeletonizing the image using “Plugins - Skeleton - Skeletonize 553 
(2D/3D)” and analyzing the processed image, by clicking “Analyze - Skeleton - Analyze Skeleton (2D/3D) 554 
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[85]. This provides results about number of junctions and branch lengths. Branches which were less than 555 
5µm were excluded to avoid small non-fibrous particles, which can influence the total branch length. All 556 
the other branches were added up to get total branch length and junctions were added to get the total 557 
number of junctions per condition. Histogram was generated to depict the number of branches in each 558 
condition, binned by branch lengths. 559 
 560 
 Statistics 561 
Two sample t-test was used to determine significance of the difference in protein staining intensities, 562 
(tissue and cell immunofluorescence), and mRNA levels (qPCR). One-way ANOVA was used to analyze 563 
significance for the difference in elastin content and crosslinks (biochemical analysis).  Chi-square test was 564 
used to determine the significance of the deviation of mouse strain survival from the Mendelian ratio by 565 
comparing the number of observed live mice to that of the expected Mendelian ratio. For all statistical 566 
analyses * denotes p≤0.05, ** denotes p≤0.01 and *** denotes p≤0.001.  567 
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Supplemental Figure legends: 
 
S1 Fig  Analysis of matrix integrity of the aorta in cFN iKO mice at 8 months of age.  
A-B) Fibrillin-1 immunostaining of cross sections of descending aorta show no change between cFN iKO 
and control at 8 months (n=3). C-D) Hart’s elastin stained cross-sections of descending aorta of tamoxifen 
injected control and cFN iKO at 8 months. E-F) Quantification of breaks (E) and forks (F) in the elastic 
lamellae normalized to the area (10,000 µm2) of the aortic section analyzed in the cFN iKO and control at 
8 months (n=8-10). There was a trend towards more elastin fiber breaks and less forks in the cFN iKO, but 
it did not reach statistical significance. Underlying data are provided in S1 Data.   Scale represents 50µm 
in A-D. Lumen is indicated with an asterisk in A-D. 
 
S2 Fig  Analysis of cellular and matrix integrity of the aorta in pFN KO mice at P30 
A-B) Hematoxylin and eosin stained cross sections of descending aorta from pFN KO (B) and control (A) 
mice at P30. Note no difference observed in the organization of SMCs in the tunica media. C-D) Masson’s 
trichrome staining of cross sections of descending aorta from control (C) and pFN KO (D) mice at P30 
showed no changes in collagen deposition. E-F) Immunostaining of cross sections of descending aorta 
from pFN KO (F) at P30 using fibrillin-1 antibody showed no changes in fibrillin-1 deposition as compared 
to the control (E). The lumen is indicated with an asterisk in A-F. 
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S3 Fig Disorganized tunica intima in the aorta of dKO mice using transmission electron microscopy 
More examples of defective elastic lamellae (yellow triangles) and irregular shaped nuclei (red triangles) 
observed in the cross sections of dKO aorta on analyzing with transmission electron microscopy. Scale bar 
represents 10µm and asterisk (*) denotes aortic lumen. 
 
S4 Fig Quantitative PCR analysis of aortae from FN KO mice.  
Quantitative PCR was performed with total RNA isolated from descending aortae of tamoxifen-injected 
mice as indicated at P8 (n=3). mRNA levels of the proteins analyzed in immunostaining (Fig 6 A-D) did not 
alter, except for FBN-1, validating the role of FN as a master organizer in ECM protein assembly, but not 
in mRNA expression. Underlying data are provided in S1 Data. 
 
S5 Fig Analysis of deoxycholate extracted fractions from vSMCs. 
 Immunoblot of FN using deoxycholate extracted fractions showed complete absence of FN assembly in 
4-hydroxytamoxifen treated vSMCs as compared to the ethanol treated cells (n=3). R indicates reducing 
conditions with 20mM dithiothreitol and NR represents non-reducing conditions. The arrow indicates FN 
monomers. 
 
 
 








Table S1. Parameters of extracellular matrix fibers shown in Figure 7F quantified using Fiji (see Materials 
and Methods). 
Proteins Parameters cFN+/pFN+ cFN+/pFN- cFN-/pFN+ 
FN Fiber length (µM) 4592 2119 1969 
 Number of Junctions 809 190 343 
FBN-1 Fiber length (µM) 4435 1245 52 
 Number of Junctions 883 164 56 
FBLN-4 Fiber length (µM) 5468 3633 3656 
 Number of Junctions 2583 842 1387 
LTBP-4 Fiber length (µM) 1460 903 576 
 Number of Junctions 735 589 307 
No measurable fibers present in the “cFN-/pFN-” sample. Numbers are presented per 0.1 mm2. 
Table S2. Parameters of extracellular matrix fibers shown in Figure 8 quantified using Fiji (see Materials 
and Methods). 
Proteins Parameters cFN added pFN added 
FN Fiber length (µM) 3629 2692 
 Number of Junctions 301 213 
FBN-1 Fiber length (µM) 6251 3512 
 Number of Junctions 598 361 
FBLN-4 Fiber length (µM) 7070 3745 
 Number of Junctions 554 253 
LTBP-4 Fiber length (µM) 2107 191 
 Number of Junctions 158 8 
No measurable fibers present in the “TBS added” sample. Numbers are presented per 0.1 mm2. 





